Europe

U.K. forms early access to medicines scheme

Monday, March 17, 2014 01:41 PM

The U.K. government has announced a new scheme that aims to give patients with life-threatening or seriously debilitating conditions access to medicines that do not yet have a marketing authorization.

More... »

WIRB Copernicus Group

New IMI project to incorporate real-life data into drug development

Thursday, March 13, 2014 12:54 PM

The Innovative Medicines Initiative (IMI) has launched a new project called GETREAL that will investigate new ways to integrate data from real-life settings, such as clinics, into drug development in Europe. This will assist healthcare decision makers in choosing how best to grant patients access to a new treatment and help pharmaceutical companies make better decisions during drug development.

More... »

CRF Health eCOA webinar series

EFPIA responds to new Clinical Trials regulation

Wednesday, March 12, 2014 02:23 PM

The European Federation of Pharmaceutical Industries and Associations (EFPIA) welcomes the political agreement reached by the European co-­legislators, with the aim of a rapid adoption of the new Regulation on Clinical Trials. However, the original objectives of this legislation should be remembered: to enhance efficiency in the clinical trials regulation process and, in turn, to boost the European Union's competitiveness as a place to conduct research and make for more efficient patients access to new innovative treatments. EFPIA believes some of the initial objectives of the legislation have been only partially achieved; therefore, the success of this legislation strongly depends on how it will apply in practice.  

More... »

MAHSC, Roche partner

Wednesday, March 12, 2014 01:50 PM

Researchers and clinicians from Manchester Academic Health Science Center (MAHSC), a partnership involving the University of Manchester and six NHS Trusts, have launched a major partnership with global pharmaceutical company Roche. The new relationship will boost clinical research studies, which could lead to the development of new drugs and diagnostic tools and give patients in the region greater access to new treatments in development.

More... »

AstraZeneca sells Alderley Park site in Cheshire, U.K.

Wednesday, March 12, 2014 01:41 PM

AstraZeneca has sold its Alderley Park site in Cheshire, U.K., to Manchester Science Parks(MSP), a Greater Manchester-based public-private partnership and science park operator.

More... »

KCR opens new entities in Western Europe

Wednesday, March 5, 2014 01:33 PM

European CRO KCR, which operates across 18 countries in Europe as well as in the U.S., has recently registered new entities in the U.K. and Germany. This move is part of the company’s strategy to bring the business closer to Western European customers and deepen client relationships.

More... »

$4.1 million launches new imaging center for personalized medicines in Scotland

Wednesday, March 5, 2014 01:17 PM

A new imaging center, to be part of the University of Glasgow’s $21 million Clinical Research Facility on the New South Glasgow Hospital site, will contribute to the creation of personalized medicines. Scottish Health Secretary Alex Neil announced the $4.1 million in funding.

More... »

vfa CEO responds to German pharmaceutical policy changes

Monday, March 3, 2014 12:46 PM

The German Bundestag is implementing a number of pharmaceutical policy changes within the scope of the 14th law amending Book V of the German Social Code, including an extension of the drug price freeze to 2017.

More... »

Evolution Scientific joins SAFE-BioPharma

Friday, February 28, 2014 12:05 PM

Evolution Scientific (ESi), a technical service provider to the pharmaceutical, biotech, medical device and other regulated industries, has joined SAFE-BioPharma Association, the nonprofit industry coalition responsible for the ongoing development and implementation of the SAFE-BioPharma digital identity and signature standard.

More... »

AstraZeneca scientists to work alongside researchers at Cancer Research UK Cambridge

Monday, February 24, 2014 11:38 AM

AstraZeneca has entered into a collaboration with the Cancer Research U.K. (CRUK) Cambridge Institute to temporarily locate up to 60 AstraZeneca scientists in the Institute.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs